Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2002 (LINC02002)

Target
LINC02002
Molecular classification
Long non-coding RNA, Intergenic non-coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 2002 (LINC02002) is a member of the long non-coding RNA (lncRNA) family, specifically classified as a long intergenic non-coding RNA (lincRNA)[1][3]. LincRNAs are autonomously transcribed RNA molecules over 200 nucleotides in length that do not overlap annotated protein-coding genes[3][5]. While the specific function and disease relevance of LINC02002 have not been characterized, lincRNAs in general have been shown to play roles in chromatin remodeling, regulation of gene expression in *cis* or *trans*, and possibly in cellular differentiation and development. Some lincRNAs function as enhancers or scaffolds for chromatin-modifying complexes, and they are under active investigation for their roles in cancer and other diseases[3][5]. There is currently **no evidence to support LINC02002 as a direct therapeutic target, biomarker, or established disease gene**[1]. LINC02002 is a long non-coding RNA of the lincRNA subtype with no documented function or therapeutic relevance as of current knowledge; it does not function as a receptor, enzyme, transporter, or drug target[1][3][5].

Other names
LINC02002
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2002 (LINC02002).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2002 (LINC02002).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call